Literature DB >> 17149577

Is short-course radiotherapy with high doses per fraction the appropriate regimen for metastatic spinal cord compression in colorectal cancer patients?

Dirk Rades1, Jochen Dahm-Daphi, Volker Rudat, Rainer Schulte, Lukas J A Stalpers, Theo Veninga, Peter J Hoskin.   

Abstract

BACKGROUND AND
PURPOSE: Various radiotherapy (RT) schedules are used worldwide for metastatic spinal cord compression (MSCC). Every treatment session may cause discomfort to the mostly debilitated patients. A short overall treatment time appears beneficial, especially for MSCC patients with an extremely poor survival such as colorectal cancer patients. This study evaluates whether short-course RT (1 x 8 Gy given in 1 day, 5 x 4 Gy given in 1 week) is as effective as long-course RT (10 x 3 Gy given in 2 weeks, 15 x 2.5 Gy given in 3 weeks, 20 x 2 Gy given in 4 weeks) and whether higher doses per fraction (more cell kill) and shorter overall treatment time (less repopulation) can compensate for lower total doses. PATIENTS AND METHODS: 81 colorectal cancer patients with MSCC were retrospectively investigated. The following potential prognostic factors for functional outcome were analyzed: age, sex, performance status, number of involved vertebrae, ambulatory status before RT, time of developing motor deficits before RT, radiation regimen (short-course, n = 31, vs. long-course RT, n = 50).
RESULTS: Improvement of motor function occurred in 14% of the patients, no change in 68%, and deterioration in 19%. There were no significant differences between short-course and long-course RT regarding improvement or deterioration of motor function (p = 0.50). Time of developing motor deficits before RT was the only significant prognostic parameter for functional outcome (> 7 days better than 1-7 days; p < 0.001).
CONCLUSION: No significant difference was observed between short-course and long-course RT with respect to functional outcome. In the clinical situation, short-course RT may be considered preferable, as it means less patient discomfort.

Entities:  

Mesh:

Year:  2006        PMID: 17149577     DOI: 10.1007/s00066-006-1578-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  6 in total

1.  Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.

Authors:  Katja Freundt; Thekla Meyners; Amira Bajrovic; Hiba Basic; Johann H Karstens; Irenaeus A Adamietz; Volker Rudat; Steven E Schild; Juergen Dunst; Dirk Rades
Journal:  Strahlenther Onkol       Date:  2010-03-26       Impact factor: 3.621

Review 2.  Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia.

Authors:  Rachid Haidar; Hani Mhaidli; Ali T Taher
Journal:  Eur Spine J       Date:  2010-03-05       Impact factor: 3.134

3.  Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States.

Authors:  B Ashleigh Guadagnolo; Kai-Ping Liao; Linda Elting; Sharon Giordano; Thomas A Buchholz; Ya-Chen Tina Shih
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

4.  New approach for treatment of vertebral metastases using intensity-modulated radiotherapy.

Authors:  Toshihiko Inoue; Ryoong-Jin Oh; Hiroya Shiomi
Journal:  Strahlenther Onkol       Date:  2011-01-21       Impact factor: 3.621

Review 5.  The role of radiotherapy for metastatic epidural spinal cord compression.

Authors:  Dirk Rades; Janet L Abrahm
Journal:  Nat Rev Clin Oncol       Date:  2010-08-31       Impact factor: 66.675

Review 6.  Comparison of Short-Course Radiotherapy Versus Long-Course Radiotherapy for Treatment of Metastatic Spinal Cord Compression: A Systematic Review and Meta-Analysis.

Authors:  Song Qu; Hui-Ling Meng; Zhong-Guo Liang; Xiao-Dong Zhu; Ling Li; Ling-Xiao Chen; Zhi-Rui Zhou
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.